Cart 12 Product Products 3 864,16 € (empty)
No products
To be determined Shipping
3 864,16 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 12 items in your cart. There is 1 item in your cart.
Total products (tax excl.) 3 864,16 €
Total shipping (tax excl.) To be determined
Total (tax excl.) 3 864,16 €
Data sheet of MUC1 monoclonal antibody, clone C595(NCRC48)
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Mouse |
| Applications | WB,ELISA,IHC-P |
More info about MUC1 monoclonal antibody, clone C595(NCRC48)
| Brand: | Abnova |
| Reference: | MAB3991 |
| Product name: | MUC1 monoclonal antibody, clone C595(NCRC48) |
| Product description: | Mouse monoclonal antibody raised against native MUC1. |
| Clone: | C595(NCRC48) |
| Isotype: | IgG3 |
| Gene id: | 4582 |
| Gene name: | MUC1 |
| Gene alias: | CD227|EMA|H23AG|MAM6|PEM|PEMT|PUM |
| Gene description: | mucin 1, cell surface associated |
| Immunogen: | Native purified MUC1 from human urinary. |
| Form: | Liquid |
| Concentration: | 100 ug/mL |
| Recommend dilutions: | Western Blot (1:20-1:100) Immunohistochemistry (1:20-1:100) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In phosphate buffer, pH 7.3 (0.09% sodium azide) |
| Storage instruction: | Store at 4°C. Do not freeze. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Mouse |
| Antigen species / target species: | Human |
| Specificity: | This antibody reacts with human MUC-1. No cross-reactivity to other tumour-associated antigens like AFP, CEA, PAP, PSA, CA19-9 and CA125. |
| Reactivity: | Human |
| Applications: | WB,ELISA,IHC-P |
| Shipping condition: | Blue Ice |
| Publications: | Primary sequence determination and molecular modelling of the variable region of an antiMUC1 mucin monoclonal antibody.Denton G, Davies GM, Scanlon MJ, Tendler SJ, Price MR. Eur J Cancer. 1995;31A(2):214-21. |